CUSIP 04390B105SPONSORED ADSAAPGQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
12 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Point72 Asset Management, L.P. | 16.7K | $438.9K | +16.7K | New |
| 2 | Xy Capital Ltd | 13.6K | $357.6K | −4.5K | Reduced |
| 3 | Citadel Advisors LLC | 9.7K | $255.0K | +85 | Added |
| 4 | Ubs Group AG | 4.2K | $111.0K |
| Reduced |
| 5 | Mirae Asset Global Investments Co., Ltd. | 2.5K | $66.8K | +83 | Added |
| 6 | Tower Research Capital LLC (Trc) | 230 | $6.0K | −599 | Reduced |
| 7 | Osaic Holdings, Inc. | 220 | $5.8K | 0 | Held |
| 8 | Bank Of America Corp /De/ | 201 | $5.3K | +21 | Added |
| 9 | Morgan Stanley | 153 | $4.0K | −50 | Reduced |
| 10 | Bell Investment Advisors, Inc | 67 | $1.8K | 0 | Held |
See every fund holding Ascentage Pharma Group Intl, with full quarter-over-quarter share changes.
Unlock all holders